AstraZeneca enters obesity market with $2b deal for GLP-1 candidate
AstraZeneca has signed an exclusive license agreement with Shanghai-based biotech Eccogene for ECC5004, an early-stage investigational...
AstraZeneca enters obesity market with $2b deal for GLP-1 candidate
Lilly's Mounjaro (tirzepatide) receives UK marketing authorisation for weight management
Low risk of bowel resection is low in patients presenting with small bowel obstruction post-RYGB
Activating pathway promotes population of insulin-producing cells and enhances cells' function
FDA approves Lilly's Zepbound (tirzepatide) for chronic weight management
Journal Watch 8/11/2023